title: Offering HPV vaccination to women treated for high-grade cervical intra-epithelial neoplasia: what do you need to know?
authors.affiliation: National HPV Vaccination Program Register, VCS Inc., East Melbourne, Victoria, Australia. jbrother@vcs.org.au.
authors.forename: Julia M L
authors.initials: JM
authors.lastname: Brotherton
authors.forename: C David H
authors.initials: CD
authors.lastname: Wrede
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000276:immunology; D010353:Patient Education as Topic; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000601:surgery; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control* / Q000601:surgery
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines